Literature DB >> 20815187

Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Tiffany J Braley1, Ronald D Chervin.   

Abstract

Among patients with multiple sclerosis (MS), fatigue is the most commonly reported symptom, and one of the most debilitating. Despite its high prevalence and significant impact, fatigue is still poorly understood and often under-emphasized because of its complexity and subjective nature. In recent years, an abundance of literature from specialists in sleep medicine, neurology, psychiatry, psychology, physical medicine and rehabilitation, and radiology have shed light on the potential causes, impact, and treatment of MS-related fatigue. Though such a diversity of contributions clearly has advantages, few recent articles have attempted to synthesize this literature, and existing overviews have focused primarily on potential causes of fatigue rather than clinical evaluation or treatment. The aims of this review are to examine, in particular for sleep specialists, the most commonly proposed primary and secondary mechanisms of fatigue in MS, tools for assessment of fatigue in this setting, and available treatment approaches to a most common and challenging problem.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20815187      PMCID: PMC2910465          DOI: 10.1093/sleep/33.8.1061

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  73 in total

1.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

Authors:  P Flachenecker; T Kümpfel; B Kallmann; M Gottschalk; O Grauer; P Rieckmann; C Trenkwalder; K V Toyka
Journal:  Mult Scler       Date:  2002-12       Impact factor: 6.312

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

Authors:  D C Kroencke; S G Lynch; D R Denney
Journal:  Mult Scler       Date:  2000-04       Impact factor: 6.312

4.  Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse).

Authors:  R N Auer; C G Rowlands; S F Perry; J E Remmers
Journal:  Clin Neuropathol       Date:  1996 Mar-Apr       Impact factor: 1.368

5.  Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine.

Authors:  A Chesson; K Hartse; W M Anderson; D Davila; S Johnson; M Littner; M Wise; J Rafecas
Journal:  Sleep       Date:  2000-03-15       Impact factor: 5.849

6.  Epidemiology of restless legs symptoms in adults.

Authors:  B Phillips; T Young; L Finn; K Asher; W A Hening; C Purvis
Journal:  Arch Intern Med       Date:  2000-07-24

7.  Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Authors:  B Stankoff; E Waubant; C Confavreux; G Edan; M Debouverie; L Rumbach; T Moreau; J Pelletier; C Lubetzki; M Clanet
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

8.  Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status.

Authors:  G Merlino; L Fratticci; C Lenchig; M Valente; D Cargnelutti; M Picello; A Serafini; P Dolso; G L Gigli
Journal:  Sleep Med       Date:  2008-01-22       Impact factor: 3.492

9.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

10.  Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study.

Authors:  Mauro Manconi; Luigi Ferini-Strambi; Massimo Filippi; Enrica Bonanni; Alfonso Iudice; Luigi Murri; Gian Luigi Gigli; Lara Fratticci; Giovanni Merlino; Giovanni Terzano; Franco Granella; Liborio Parrino; Rosalia Silvestri; Irene Aricò; Vincenzo Dattola; Giovanna Russo; Carmela Luongo; Alessandro Cicolin; Antonella Tribolo; Paola Cavalla; Mariantonietta Savarese; Maria Trojano; Salvatore Ottaviano; Fabio Cirignotta; Valentina Simioni; Fabrizio Salvi; Fiorella Mondino; Franco Perla; Giorgia Chinaglia; Cristina Zuliani; Edward Cesnik; Enrico Granieri; Fabio Placidi; Maria Giuseppina Palmieri; Raffaele Manni; Michele Terzaghi; Roberto Bergamaschi; Raffaele Rocchi; Monica Ulivelli; Sabina Bartalini; Raffaele Ferri; Salvatore Lo Fermo; Emilio Ubiali; Massimo Viscardi; Mariarosa Rottoli; Lino Nobili; Alessandra Protti; Franco Ferrillo; Marta Allena; Gianluigi Mancardi; Biancamaria Guarnieri; Francesco Londrillo
Journal:  Sleep       Date:  2008-07       Impact factor: 5.849

View more
  73 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

2.  Assessing fatigue in multiple sclerosis: shedding light on the elephant in the dark.

Authors:  Michael J Decker
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

3.  Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study.

Authors:  Robert A Dias; Kimberly A Hardin; Heather Rose; Mark A Agius; Michelle L Apperson; Steven D Brass
Journal:  Sleep Breath       Date:  2012-01-21       Impact factor: 2.816

4.  High dose thiamine improves fatigue in multiple sclerosis.

Authors:  Antonio Costantini; Agostino Nappo; Maria Immacolata Pala; Antonietta Zappone
Journal:  BMJ Case Rep       Date:  2013-07-16

5.  Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial.

Authors:  Catherine F Siengsukon; Mohammed Alshehri; Cierra Williams; Michelle Drerup; Sharon Lynch
Journal:  Mult Scler Relat Disord       Date:  2020-01-23       Impact factor: 4.339

6.  Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years.

Authors:  Sarah D Broicher; Linard Filli; Olivia Geisseler; Nicole Germann; Björn Zörner; P Brugger; M Linnebank
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

Review 7.  Fatigue Can Be Objectively Measured in Multiple Sclerosis: Multipl Sklerozda Yorgunluk Objektif Olarak Ölçülebilir.

Authors:  Haluk Gümüş
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

8.  Is anemia a probable cause of fatigue in patients with multiple sclerosis?

Authors:  Soha Mir-Reza; Maryam Tabatabaeiyan; Rozita Doosti; Mahsa Owji; Abdorreza Naser Moghadasi
Journal:  Iran J Neurol       Date:  2013

Review 9.  4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.

Authors:  Henrik Boye Jensen; Mads Ravnborg; Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

10.  Fatigue and Comorbidities in Multiple Sclerosis.

Authors:  Kirsten M Fiest; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kyla A McKay; Lindsay I Berrigan; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.